APA (7th ed.) Citation

Barbanti, P., Aurilia, C., Filippi, M., Doretti, A., d’Onofrio, F., Scatena, P., . . . Camarda, C. (2026). Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study. Neurology & Therapy, 1. https://doi.org/10.1007/s40120-026-00971-7

Chicago Style (17th ed.) Citation

Barbanti, Piero, et al. "Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study." Neurology & Therapy 2026: 1. https://doi.org/10.1007/s40120-026-00971-7.

MLA (9th ed.) Citation

Barbanti, Piero, et al. "Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study." Neurology & Therapy, 2026, p. 1, https://doi.org/10.1007/s40120-026-00971-7.